Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study
Titel:
Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study
Auteur:
Herling, Carmen D Coombes, Kevin R Benner, Axel Bloehdorn, Johannes Barron, Lynn L Abrams, Zachary B Majewski, Tadeusz Bondaruk, Jolanta E Bahlo, Jasmin Fischer, Kirsten Hallek, Michael Stilgenbauer, Stephan Czerniak, Bogdan A Oakes, Christopher C Ferrajoli, Alessandra Keating, Michael J Abruzzo, Lynne V